GreenLight Biosciences (NASDAQ:GRNA), which combined with Environmental Impact in February 2022, announced this morning that it is being acquired in a go-private transaction by Fall Line Capital for $45.5 million.
While this is a steep valuation decline from its $1.23 billion enterprise value at the announcement of its SPAC deal, this price does represent a 50% premium to GreenLight’s last closing price.
Shareholders owning 79.5% of GreenLight’s outstanding equity have agreed to exchange shares for Series A-2 preferred stock in a new holding company that will own the group. The company is also to receive $15 million in cash and issue $15 million in unsecured notes for working capital purposes.
Fall Line aims to supplement this with sales of $100 million in convertible secured promissory notes in the company to further fund it at close and has gathered about $52 million of this amount so far.
GreenLight, which is developing RNA-based vaccines for human health and agricultural crop protection, previewed the deal in its May 11 earnings release, noting that it received an indication of interest from Fall Line in March.
That news was accompanied with results showing that the company’s cash reserves were depleting rapidly to $32.4 million as of the end of the first quarter, down from $68.1 million in December. It predicted that this would be enough to get it through the second quarter, but some other move would be required to extend its runway thereafter.
This was the tail end of GreenLight’s SPAC proceeds, which included a $124 million PIPE. But, the company’s high R&D costs, coupled with just $3.8 million in revenue in the first quarter coming from collaborations have left it on an unsustainable path.
Fortunately, its existing backers are still believers. Fall Line was an investor in its PIPE, and it own investment portfolio is made up of farmland it manages and technology companies it views as strategic to those farms’ success.
As such, GreenLight will be able to continue its work from a private position over the medium term. And, should it regain its footing, it may have the chance at another to back to the public markets in a climate more supportive to early tech ventures.
LatAmGrowth SPAC (NASDAQ:LATG) announced in a filing this morning that it will once adjourn its special meeting to liquidate early a second time and will reconvene it at October 5. The proposals on its ballot would initiate the process of winding down the SPAC and return all trust capital to investors outside of $100,000 for...
Jaguar Global (NASDAQ:JGGC) announced this morning that its shareholders approved its combination with glass-maker GLAAM at a special meeting September 27. The parties have not yet released redemption figures or a timeline to close, but the combined company is expected to change its name to Captivision. Upon close its shares and warrants are to trade...
Mercato Partners (NASDAQ:MPRA) announced in an 8-K this morning that it has tacked on $1.7 million more to the PIPE for its combination with Brazilian software firm Nuvini. The move comes as its shareholders are to vote to complete the deal later today and adds to $11.1 million in PIPE funds it secured earlier this...
Crixus BH3 (NASDAQ:BHAC) announced in an 8-K this morning that it will sell its most of its sponsor shares and warrants to a new sponsor entity, which will continue to lead the SPAC. The new sponsor is to buy up 3,746,303 promote shares (65.1%) and 4,160,000 (65%) of the original sponsor’s private placement warrrants for...
GigCapital 5, Inc. (GIA) Signs Non-Redemption Agreements GigCapital 5 (NASDAQ:GIA) announced in an 8-K this morning that it has entered non-redemption agreements with third parties that will secure up to 2,042,903 shares from redemption. One of these third parties is Meteora Capital Partners and the investors have made this commitment with the caveat that none...